Daniel Manwaring
First SEC filing: April 6, 2026 · Latest: April 6, 2026
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 7, 2026 | IMAX | A | 5,072 | · | · | 5,072 Direct | · | Acquired | (price as of 2026-10-02) |
| March 7, 2026 | IMAX | M | 4,666 | · | · | 9,334 Direct | -33.33% | Disposed | (price as of 2026-10-02) |
| March 7, 2026 | IMAX | M | 7,409 | · | · | 7,410 Direct | -50.00% | Disposed | (price as of 2026-10-02) |
| March 7, 2026 | IMAX | F | 4,790 | $40.80 | $195,432 | 12,363 Direct | -27.93% | Disposed | 29.2% (price as of 2026-10-02) |
| March 7, 2026 | IMAX | M | 4,666 | · | · | 17,153 Direct | +37.37% | Acquired | (price as of 2026-10-02) |
| March 7, 2026 | IMAX | M | 7,409 | · | · | 12,487 Direct | +145.90% | Acquired | (price as of 2026-10-02) |
| March 7, 2026 | IMAX | A | 5,072 | · | · | 5,072 Direct | · | Acquired | (price as of 2026-10-02) |
| March 7, 2026 | IMAX | M | 4,666 | · | · | 9,334 Direct | -33.33% | Disposed | (price as of 2026-10-02) |
| March 7, 2026 | IMAX | M | 7,409 | · | · | 7,410 Direct | -50.00% | Disposed | (price as of 2026-10-02) |
| March 7, 2026 | IMAX | F | 5,435 | $40.80 | $221,748 | 11,718 Direct | -31.69% | Disposed | 29.2% (price as of 2026-10-02) |
| March 7, 2026 | IMAX | M | 4,666 | · | · | 17,153 Direct | +37.37% | Acquired | (price as of 2026-10-02) |
| March 7, 2026 | IMAX | M | 7,409 | · | · | 12,487 Direct | +145.90% | Acquired | (price as of 2026-10-02) |
| March 7, 2025 | IMAX | A | 14,000 | · | · | 14,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 7, 2025 | IMAX | M | 7,409 | · | · | 14,819 Direct | +99.99% | Acquired | (price as of 2026-10-02) |
| March 7, 2025 | IMAX | F | 2,331 | $25.26 | $58,881 | 5,078 Direct | -31.46% | Disposed | 108.7% (price as of 2026-10-02) |
| March 7, 2025 | IMAX | M | 7,409 | · | · | 7,409 Direct | · | Acquired | (price as of 2026-10-02) |
| March 7, 2025 | IMAX | A | 14,000 | · | · | 14,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 7, 2025 | IMAX | M | 7,409 | · | · | 14,819 Direct | +99.99% | Acquired | (price as of 2026-10-02) |
| March 7, 2025 | IMAX | F | 2,297 | $25.26 | $58,022 | 5,112 Direct | -31.00% | Disposed | 108.7% (price as of 2026-10-02) |
| March 7, 2025 | IMAX | M | 7,409 | · | · | 7,409 Direct | · | Acquired | (price as of 2026-10-02) |
| March 7, 2024 | IMAX | A | 22,228 | · | · | 22,228 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 7, 2026 | IMAX | restricted share units [F3] | common shares | · | · | 5,072 | Acquired |
| March 7, 2026 | IMAX | restricted share units [F3] | common shares | · | · | 4,666 | Disposed |
| March 7, 2026 | IMAX | restricted share units [F3] | common shares | · | · | 7,409 | Disposed |
| March 7, 2026 | IMAX | restricted share units [F3] | common shares | · | · | 5,072 | Acquired |
| March 7, 2026 | IMAX | restricted share units [F3] | common shares | · | · | 4,666 | Disposed |
| March 7, 2026 | IMAX | restricted share units [F3] | common shares | · | · | 7,409 | Disposed |
| March 7, 2025 | IMAX | restricted share units [F3] | common shares | · | · | 14,000 | Acquired |
| March 7, 2025 | IMAX | restricted share units [F3] | common shares | · | · | 7,409 | Acquired |
| March 7, 2025 | IMAX | restricted share units [F3] | common shares | · | · | 14,000 | Acquired |
| March 7, 2025 | IMAX | restricted share units [F3] | common shares | · | · | 7,409 | Acquired |
| March 7, 2024 | IMAX | restricted share units [F1] | common shares | · | · | 22,228 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $589,080 | $75,000 | · | · | $270,185 | · | $267,835 | $1,927,099 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.